UHPLC for the separation of proteins and peptides

Bioanalysis

Volumn 4, Issue 24, 2012, Pages 2971-2988

  Howard, James W ^a   Kay, Richard G ^a   Pleasance, Steve ^a   Creaser, Colin S ^b  

^a Quotient Bioresearch Ltd   (United Kingdom)

^b LOUGHBOROUGH UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PEPTIDE; PROTEIN;

CONTROLLED STUDY; DRUG DEVELOPMENT; DRUG INDUSTRY; IMMUNOCHEMISTRY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METHODOLOGY; PEPTIDE ANALYSIS; PROTEIN ANALYSIS; REVIEW; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, LIQUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MASS SPECTROMETRY; PEPTIDES; PROTEINS;

EID: 84871306957     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.12.283     Document Type: Review

References (65)

1. Rishabh P, Av S, Awanish P, Poonam T, Majumdar SK, Lk N. Protein and peptide drugs: a brief review. Res. J. Pharm. Tech. 2 2(2), 228-233 (2009).
2. Boehmer JL, DeGrasse JA, McFarland MA et al. The proteomic advantage: label-free quantification of proteins expressed in bovine milk during experimentally induced coliform mastitis. Vet. Immunol. Immunop. 138(4), 252-266 (2010).
3. Hagman C, Ricke D, Ewert S, Bek S, Falchetto R, Bitsch F. Absolute quantification of monoclonal antibodies in biofluids by liquid chromatography-tandem mass spectrometry. Anal. Chem. 80(4), 1290-1296 (2008).
4. Keshishian H, Addona T, Burgess M, Kuhn E, Carr SA. Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution. Mol. Cell. Proteomics 6(12), 2212-2229 (2007).
5. Kehler JR, Bowen CL, Boram SL, Evans CA. Application of DBS for quantitative assessment of the peptide Exendin-4; comparison of plasma and DBS method by UHPLC-MS/MS. Bioanalysis 2(8), 1461-1468 (2010).
6. Kuzyk MA, Smith D, Yang J et al. Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma. Mol. Cell. Proteomics 8(8), 1860-1877 (2009).
7. Kay RG, Gregory B, Grace PB, Pleasance S. The application of ultra-performance liquid chromatography/tandem mass spectrometry to the detection and quantitation of apolipoproteins in human serum. Rapid Commun. Mass Spectrom. 21(16), 2585-2593 (2007).
8. Fortin T, Salvador A, Charrier JP et al. Clinical quantitation of prostate-specific antigen biomarker in the low nanogram/milliliter range by conventional bore liquid chromatography-tandem mass spectrometry (multiple reaction monitoring) coupling and correlation with ELISA tests. Mol. Cell. Proteomics 8(5), 1006-1015 (2009).
9. Yang Z, Hayes M, Fang X, Daley MP, Ettenberg S, Tse FLS. LC-MS/MS approach for quantification of therapeutic proteins in plasma using a protein internal standard and 2D-solid-phase extraction cleanup. Anal. Chem. 79(24), 9294-9301 (2007).
10. Kay RG, Barton C, Velloso CP et al. High-throughput ultra-high- performance liquid chromatography/tandem mass spectrometry quantitation of insulin-like growth factor-I and leucine-rich alpha-2-glycoprotein in serum as biomarkers of recombinant human growth hormone administration. Rapid Commun. Mass Spectrom. 23(19), 3173-3182 (2009).
11. Taieb J, Mathian B, Millot F et al. Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children. Clin. Chem. 49(8), 1381-1395 (2003).
12. Dillen L, Cools W, Vereyken L, Timmerman P. A screening UHPLC-MS/MS method for the analysis of amyloid peptides in cerebrospinal fluid of preclinical species. Bioanalysis 3(1), 45-55 (2011).
13. UK Government. The Medicines for Human Use (Clinical Trials) Regulations 2004. Lodnon, UK (2004).
14. International Committee on Harmonisation. Guideline for Good Clinical Practice. European Medicines Agency, London, UK (1996).
15. US Department of Health and Human Services, US FDA, Center for Drug Evaluation and Research, Center for Veterinary Medicine. Guidance for Industry: Bioanalytical Method Validation. Rockville, MD, USA (2001).
16. Gibiansky L, Sutjandra L, Doshi S et al. Population pharmacokinetic analysis of denosumab in patients with bone metastases from solid tumours. Clin. Pharmacokinet. 51(4), 247-260 (2012).
17. Nováková L, Vlcková H. A review of current trends and advances in modern bioanalytical methods: chromatography and sample preparation. Anal. Chim. Acta 656(1-2), 8-35 (2009).
18. Guillarme D, Ruta J, Rudaz S, Veuthey J-L. New trends in fast and high-resolution liquid chromatography: a critical comparison of existing approaches. Anal. Bio. Chem. 397(3), 1069-1082 (2010).
19. van Deemter JJ, Zuiderweg FJ, Klinkenberg A. Longitudinal diffusion and resistance to mass transfer as causes of nonideality in chromatography. Chem. Eng. Sci. 5(6), 271-289 (1956).
20. Phillips DJ, Capparella M, Neue UD, Fallah ZE. A new small particle packing for faster analysis with high resolution. J. Pharm. Biomed. Anal. 15(9-10), 1389-1395 (1997).
21. MacNair JE, Lewis KC, Jorgenson JW. Ultrahigh-pressure reversed-phase liquid chromatography in packed capillary columns. Anal. Chem. 69(6), 983-989 (1997).
22. MacNair JE, Patel KD, Jorgenson JW. Ultrahigh-pressure reversed-phase capillary liquid chromatography: isocratic and gradient elution using columns packed with 1.0-μm particles. Anal. Chem. 71(3), 700-708 (1999).
23. Cunliffe JM, Adams-Hall SB, Maloney TD. Evaluation and comparison of very high pressure liquid chromatography systems for the separation and validation of pharmaceutical compounds. J. Sep. Sci. 30(8), 1214-1223 (2007).
24. Giddings JC. Comparison of theoretical limit of separating speed in gas and liquid chromatography. Anal. Chem. 37(1), 60-63 (1965).
25. Poppe H. Some reflections on speed and efficiency of modern chromatographic methods. J. Chromatogr. A 778(1-2), 3-21 (1997).
26. Neue U. Theory of peak capacity in gradient elution. J. Chromatogr. A 1079(1-2), 153-161 (2005).
27. Wang X, Stoll DR, Carr PW, Schoenmakers PJ. A graphical method for understanding the kinetics of peak capacity production in gradient elution liquid chromatography. J. Chromatogr. A 1125(2), 177-181 (2006).
28. Fekete S, Ganzler K, Fekete J. Facts and myths about columns packed with sub-3 microm and sub-2 microm particles. J. Pharm. Biomed. Anal. 51(1), 56-64 (2010).
29. Ruta J, Guillarme D, Rudaz S, Veuthey J-L. Comparison of columns packed with porous sub-2 microm particles and superficially porous sub-3 microm particles for peptide analysis at ambient and high temperature. J. Sep. Sci. 33(16), 2465-2477 (2010).
30. Fekete S, Rudaz S, Veuthey J-L, Guillarme D. Impact of mobile phase temperature on recovery and stability of monoclonal antibodies using recent reversed-phase stationary phases. J. Sep. Sci. doi: 10.1002/jssc.201200297 (2012) (Epub ahead of print).
31. Ismaiel OA, Zhang T, Jenkins R, Karnes HT. Determination of octreotide and assessment of matrix effects in human plasma using ultra high performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 879(22), 2081-2088 (2011).
32. Fekete S, Berky R, Fekete J, Veuthey J-L, Guillarme D. Evaluation of a new wide pore core-shell material (Aeris WIDEPORE) and comparison with other existing stationary phases for the analysis of intact proteins. J. Chromatogr. A 1236, 177-188 (2012).
33. Krokhin OV, Craig R, Spicer V et al. An improved model for prediction of retention times of tryptic peptides in ion pair reversed-phase HPLC: its application to protein peptide mapping by off-line HPLC-MALDI MS. Mol. Cell. Proteomics 3(9), 908-919 (2004).
34. Su X, Jacob NK, Amunugama R et al. Liquid chromatography mass spectrometry profiling of histones. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 850(1-2), 440-454 (2007).
35. Contrepois K, Ezan E, Mann C, Fenaille F. Ultra-high performance liquid chromatography-mass spectrometry for the fast profiling of histone post-translational modifications. J. Proteome Res. 9(10), 5501-5509 (2010).
36. Everley RA, Croley TR. Ultra-performance liquid chromatography/mass spectrometry of intact proteins. J. Chromatogr. A 1192(2), 239-247 (2008).
37. Luna LG, Williams TL, Pirkle JL, Barr Jr. Ultra performance liquid chromatography isotope dilution tandem mass spectrometry for the absolute quantification of proteins and peptides. Anal. Chem. 80(8), 2688-2693 (2008).
38. Chambers E, Wagrowski-Diehl DM, Lu Z, Mazzeo Jr. Systematic and comprehensive strategy for reducing matrix effects in LC/
39. Chakraborty AB, Berger SJ. Optimization of reversed-phase peptide liquid chromatography ultraviolet mass spectrometry analyses using an automated blending methodology. J. Biomol. Tech. 16(4), 327-335 (2005).
40. Esteve C, Del Río C, Marina ML, García MC. Development of an ultra-high performance liquid chromatography analytical methodology for the profiling of olive (Olea europaea L.) pulp proteins. Anal. Chim. Acta 690(1), 129-134 (2011).
41. Oe T, Ackermann BL, Inoue K et al. Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry. Rapid Commun. Mass Spectrom. 20(24), 3723-3735 (2006).
42. Jorgenson JW. Capillary liquid chromatography at ultrahigh pressures. Annu. Rev. Anal. Chem. 3, 129-150 (2010).
43. Eschelbach JW, Jorgenson JW. Improved protein recovery in reversed-phase liquid chromatography by the use of ultrahigh pressures. Anal. Chem. 78(5), 1697-1706 (2006).
44. Nagaraj N, Kulak NA, Cox J et al. Systems-wide perturbation analysis with near complete coverage of the yeast proteome by single-shot UHPLC runs on a bench-top Orbitrap. Mol. Cell. Proteomics 11(3), M111.013722 (2012).
45. Chen C-J, Chen W-Y, Tseng M-C, Chen Y-R. Tunnel frit: a non-metallic in-capillary frit for nano-UHPLC-MS applications. Anal. Chem. 84(1), 297-303 (2012).
46. Chloupek RC, Hancock WS, Snyder LR. Computer simulation as a tool for the rapid optimization of the high-performance liquid chromatographic separation of a tryptic digest of human growth hormone. J. Chromatogr. 594(1-2), 65-73 (1992).
47. Chen H, Horváth C. High-speed high-performance liquid chromatography of peptides and proteins. J. Chromatogr. A 705(1), 3-20 (1995).
48. Szabelski P, Cavazzini A, Kaczmarski K, Liu X, Van Horn J, Guiochon G. Experimental studies of pressure/temperature dependence of protein adsorption equilibrium in reversed-phase high-performance liquid chromatography. J. Chromatogr. A 950(1-2), 41-53 (2002).
49. Wenclawiak BW, Giegold S, Teutenberg T. High-temperature liquid chromatography. Anal. Lett. 41(7), 1097-1105 (2008).
50. Teutenberg T, Hollebekkers K, Wiese S, Boergers A. Temperature and pH-stability of commercial stationary phases. J. Sep. Sci. 32(9), 1262-1274 (2009).
51. Newby JJ, Legg MA, Rogers B, Wirth MJ. Annealing of silica to reduce the concentration of isolated silanols and peak tailing in reverse phase liquid chromatography. J. Chromatogr. A 1218(31), 5131-5135 (2011).
52. Wyndham KD, O'Gara JE, Walter TH et al. Characterization and evaluation of C18 HPLC stationary phases based on ethyl-bridged hybrid organic/inorganic particles. Anal. Chem. 75(24), 6781-6788 (2003).
53. Nováková L, Vlčková H, Petr S. Evaluation of new mixed-mode UHPLC stationary phases and the importance of stationary phase choice when using low ionic-strength mobile phase additives. Talanta 93, 99-105 (2012).
54. de Villiers A, Lestremau F, Szucs R, Gélébart S, David F, Sandra P. Evaluation of ultra performance liquid chromatography. Part I. Possibilities and limitations. J. Chromatogr. A 1127(1-2), 60-69 (2006).
55. Wang X, Barber WE, Carr PW. A practical approach to maximizing peak capacity by using long columns packed with pellicular stationary phases for proteomic research. J. Chromatogr. A 1107(1-2), 139-151 (2006).
56. Knox J, Saleem M. Kinetic conditions for optimum speed and resolution in column choromatography. J. Chromatogr. Sci. 7(10), 614-622 (1969).
57. Barton C, Kay RG, Gentzer W, Vitzthum F, Pleasance S. Development of high-throughput chemical extraction techniques and quantitative HPLC-MS/MS (SRM) assays for clinically relevant plasma proteins. J. Proteome Res. 9(1), 333-340 (2010).
58. Fekete S, Ganzler K, Fekete J. Efficiency of the new sub-2 μm core-shell (KinetexTM) column in practice, applied for small and large molecule separation. J. Pharmaceut. Biomed. 54(3), 482-490 (2011).
59. Kaczmarski K, Guiochon G. Modeling of the mass-transfer kinetics in chromatographic columns packed with shell and pellicular particles. Anal. Chem. 79(12), 4648-4656 (2007).
60. Fortin T, Salvador A, Charrier JP et al. Multiple reaction monitoring cubed for protein quantification at the low nanogram/milliliter level in nondepleted human serum. Anal. Chem. 81(22), 9343-9352 (2009).
61. Lassman ME, McLaughlin TM, Somers EP et al. A rapid method for cross species quantitation of apolipoproteins A1, B48 and B100 in plasma by ultra performance liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 26(2), 101-108 (2012).
62. Kehler J, Akella N, Citerone D, Szapacs M. Application of DBS for the quantitative assessment of a protein biologic using on-card digestion LC-MS/MS or immunoassay. Bioanalysis 3(20), 2283-2290 (2011).
63. Mittelmaier S, Pischetsrieder M. Multistep ultrahigh performance liquid chromatography/tandem mass spectrometry analysis for untargeted quantification of glycating activity and identification of most relevant glycation products. Anal. Chem. 83(24), 9660-9668 (2011).
64. Zamani L, Andersson FO, Edebrink P, Yang Y, Jacobsson SP. Conformational studies of a monoclonal antibody, IgG1, by chemical oxidation: structural analysis by ultrahigh-pressure LC-electrospray ionization time-of-flight MS and multivariate data analysis. Anal. Biochem. 380(2), 155-163 (2008).
65. Switzar L, Giera M, Lingeman H, Irth H, Niessen WMA. Protein digestion optimization for characterization of drug-protein adducts using response surface modeling. J. Chromatogr. A 1218(13), 1715-1723 (2010).